How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Next Generation Implants (NGI) Market
- By Implant Type: Orthopedic Implants, Dental Implants, Cochlear Implants, Cardiac Implants, Neurostimulator Implants
- By Material Type: Titanium Alloys, Ceramic Materials, Polyether Ether Ketone (PEEK), Biodegradable Polymers, Cobalt-Chromium Alloys
- By Technology: 3D Printed Implants, Smart Implants with Sensors, Bioactive Coated Implants, Nanotechnology-Enhanced Implants, Drug-Eluting Implants
- By Application: Spinal Fusion, Joint Replacement, Craniofacial Reconstruction, Dental Restoration, Cardiac Rhythm Management
- By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Dental Clinics, Research Institutes
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Orthopedic Implants leads By Implant Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Next Generation Implants (NGI) Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Implant Type 5
Material Type 5
Technology 5
Application 5
End User 5
Companies profiled
Medtronic
Stryker Corporation
Zimmer Biomet Holdings Inc.
DePuy Synthes (Johnson & Johnson)
NuVasive Inc.
Globus Medical Inc.
Smith & Nephew plc
Orthofix International N.V.
Exactech Inc.
Mizuho OSI
Aesculap Implant Systems (B. Braun)
Conformis Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Zimmer Biomet Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →DePuy Synthes (Johnson & Johnson)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →NuVasive Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Globus Medical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Smith & Nephew plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Orthofix International N.V.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Exactech Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Mizuho OSI
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Aesculap Implant Systems (B. Braun)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Conformis Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →RTI Surgical Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Invibio Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →LimaCorporate
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,661M by 2033 · 7.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Orthopedic Implants30.6
- Dental Implants23.0
- Cochlear Implants20.4
- Cardiac Implants8.8
- Neurostimulator Implants17.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,811M → $3,315M · 7.9%
Europe$1,262M → $2,126M · 6.7%
Asia Pacific$1,152M → $2,048M · 7.5%
Latin America$713.3M → $1,126M · 5.9%
Middle East and Africa$548.7M → $1,056M · 8.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.282026
7.292027
7.312028
7.322029
7.322030
7.332031
7.342032
7.372033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic22.5
- Stryker Corporation13.2
- Zimmer Biomet Holdings Inc.6.6
- DePuy Synthes (Johnson & Johnson)13.8
- NuVasive Inc.9.7
- Globus Medical Inc.6.3
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Implant Type13.1%
Material Type25.0%
Technology34.0%
Application14.7%
End User13.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.3
- Europe22.0
- Asia Pacific21.2
- Latin America11.6
- Middle East and Africa10.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic | 97 | 84 | 93 | 89 | 92 | 76 | 89 |
| Stryker Corporation | 91 | 70 | 80 | 87 | 89 | 75 | 82 |
| Zimmer Biomet Holdings Inc. | 80 | 66 | 80 | 82 | 79 | 79 | 78 |
| DePuy Synthes (Johnson & Johnson) | 63 | 61 | 64 | 61 | 81 | 74 | 67 |
| NuVasive Inc. | 52 | 77 | 56 | 69 | 69 | 72 | 66 |
| Globus Medical Inc. | 49 | 68 | 64 | 69 | 49 | 63 | 60 |
| Smith & Nephew plc | 62 | 41 | 54 | 56 | 57 | 42 | 52 |
| Orthofix International N.V. | 59 | 44 | 55 | 36 | 58 | 37 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic
- Stryker Corporation
- Zimmer Biomet Holdings Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Stryker Corporation | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Zimmer Biomet Holdings Inc. | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| DePuy Synthes (Johnson & Johnson) | ◐ | ◐ | − | ✓ | ◐ | ✓ |
| NuVasive Inc. | ◐ | ✓ | − | ◐ | ✓ | ◐ |
| Globus Medical Inc. | − | ◐ | ◐ | ◐ | ◐ | − |
| Smith & Nephew plc | ◐ | − | ◐ | − | − | − |
| Orthofix International N.V. | ◐ | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic89
2Stryker Corporation82
3Zimmer Biomet Holdings Inc.78
4DePuy Synthes (Johnson & Johnson)67
5NuVasive Inc.66
6Globus Medical Inc.60
7Smith & Nephew plc52
8Orthofix International N.V.48
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
MedtronicStryker CorporationZimmer Biomet Holdings Inc.
Challenger1
Strong scale, closing on the leaders.
DePuy Synthes (Johnson & Johnson)
Contender2
Focused players with pockets of strength.
NuVasive Inc.Globus Medical Inc.
Niche2
Specialists in a single segment or region.
Smith & Nephew plcOrthofix International N.V.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Implant Type in North America, then scale across Next Generation Implants (NGI) Market — a $659M beachhead inside a $8.95B market.
Beachhead (SOM)$659Mobtainable near-term
Serviceable (SAM)$3.54Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Orthopedic Implants
Best fit — highest urgency & budget in Implant Type.
Economic buyer76 fit
Dental Implants
Strong fit — clear ROI and a fast path to value.
End user64 fit
Cochlear Implants
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Implant Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Technology
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel28%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Implant Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Next Generation Implants (NGI) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified21%
Evaluation12%
Closed-won8%
$13.1KCAC
$52KLTV
3.9:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Next Generation Implants (NGI) Market is a resilient opportunity — $3.03B by 2033, compounding at 4.0%.
TAM · 2025$2.21Btoday
TAM · 2033$3.03Bforecast
CAGR4.0%2027–2033
Cumulative$23.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.03BTotal addressable market
SAM$1.18BServiceable available market
SOM$254MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.0% CAGR
Demand compounds through 2033, outpacing GDP across Implant Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Implant Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.03BLarge & growingTAM by 2033 at 4.0% CAGR
$1.18BServiceable nowreachable with today’s model
$254MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.36BBear2.6% CAGR
$3.03BBase4.0% CAGR
$3.87BBull5.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Next Generation Implants (NGI) Market — a $2.35B market by 2033. Plan: grow share from 6.9% to 14.6%.
Market size · 2033$2.35Btotal addressable
Market CAGR9.9%2027–2033
Target share14.6%from 6.9% today
Revenue ambition$343Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.9% | 14.6% | On track |
| Revenue | $148M | $343M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 30.7% | 45.9% | On track |
| Customer retention | 86.3% | 95.2% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Implant Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material Type capability
A defensible second engine — invest in Material Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Implant Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $38M capacity & capability investment
- Greenlight bolt-on M&A in Material Type
- Authorise North America expansion plan
- Fund R&D program for Implant Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Next Generation Implants (NGI) Market conversation — a $7.85B market you can size, segment and defend in minutes.
Market size · 2033$7.85Btotal opportunity
Growth6.4%CAGR to 2033
Addressable buyers1,701+accounts in scope
Typical ROI5.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Implant Type
Goal Grow share in Implant Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.9×return on cost, year one
< 3 mopayback period
$81K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
MedtronicStryker CorporationZimmer Biomet Holdings Inc.DePuy Synthes (Johnson & Johnson)NuVasive Inc.Globus Medical Inc.Smith & Nephew plcOrthofix International N.V.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Next Generation Implants (NGI) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Next Generation Implants (NGI) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Next-Generation Immunology Drugs Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportNext-Generation Gynecological Cancer Diagnostics Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportNext Generation Cancer Treatment Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportNext Generation Cancer Diagnostics Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportNext-Generation Breast Cancer Diagnostic and Screening Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportNext-Generation Biomanufacturing Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportNext Generation Baby Safety Monitor Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportNext-Generation Antibody Drug Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportNext Generation Ablation System Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportNew Traditional Chinese Medicine Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportNew Tobacco Services Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportNew Psychoactive Substance Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.